ADS AMERICAN DRUG SCREEN CORP.

Serial Number 97237809
Registration 7334514
700

Registration Progress

Application Filed
Jan 25, 2022
Under Examination
Approved for Publication
Jan 9, 2024
Published for Opposition
Jan 9, 2024
Registered
Mar 26, 2024

Trademark Image

ADS AMERICAN DRUG SCREEN CORP.

Basic Information

Serial Number
97237809
Registration Number
7334514
Filing Date
January 25, 2022
Registration Date
March 26, 2024
Published for Opposition
January 9, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 26, 2024
Registration
Registered
Classes
035

Rights Holder

American Drug Screen Corporation

03
Address
5358 Irwindale Avenue
Irwindale, CA 91706

Ownership History

American Drug Screen Corporation

Original Applicant
03
Irwindale, CA

American Drug Screen Corporation

Owner at Publication
03
Irwindale, CA

American Drug Screen Corporation

Original Registrant
03
Irwindale, CA

Legal Representation

Attorney
Michael J. Hoisington, Esq.

USPTO Deadlines

Next Deadline
1697 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-03-26)
Due Date
March 26, 2030
Grace Period Ends
September 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Mar 26, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 26, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 29, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 29, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 28, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 28, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Aug 31, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 31, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Aug 31, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 31, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
May 16, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 16, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
May 15, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
May 15, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
May 15, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 3, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 3, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 3, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 3, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 1, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 29, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 28, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
On-line wholesale and retail store services featuring drug testing kits and devices
First Use Anywhere: 20100000
First Use in Commerce: 20100000

Additional Information

Design Mark
The mark consists of the letters "A," "D" and "S," with the letter "D" inside of a contrasting square turned at a 45 degree angle and the phrase "AMERICAN DRUG SCREEN CORP." centered underneath the letters ADS and overlapping the bottom of the rotated square design.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"AMERICAN DRUG SCREEN CORPORATION"